Evidence map›Paper›PMID 41622630›Full record

ArticleClinical and molecular hepatology2026

Noncanonical EZH2 activity cooperates with FOXM1 to drive tumorigenesis and advanced progression in HCC.

Sungju Jung, Hyun Jin Bang, Myong-Suk Park, Kyung Hwa Lee, Lothar Hennighausen, Kyung Hyun Yoo, Woo Kyun Bae

Abstract read
In one paragraph

Article in Clinical and molecular hepatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sungju JungLaboratory of Biomedical Genomics, Department of Biological Sciences, Sookmyung Women's University, Seoul, Korea.
Hyun Jin BangDepartment of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea.
Myong-Suk ParkDepartment of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea.
Kyung Hwa LeeDepartment of Pathology, Chonnam National University Medical School and Hwasun Hospital, Hwasun, Korea.
Lothar HennighausenSection of Genetics and Physiology, Digestive and Kidney Diseases, National Institute of Diabetes, National Institutes of Health, Bethesda, MD, USA.
Kyung Hyun YooLaboratory of Biomedical Genomics, Department of Biological Sciences, Sookmyung Women's University, Seoul, Korea.
Woo Kyun BaeDepartment of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea.

Funding

Ministry of Science and ICTNational Research Foundation of Korea 2020M3A9G3080281National Research Foundation of Korea RS-2021-NR060115National Research Foundation of Korea RS-2023-NR076697National Research Foundation of Korea RS-2024-00401422
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Combination therapyEZH2FOXM1H3K27me3-independent transcriptional regulationHepatocellular carcinoma

Identifiers

PMID41622630
PMCPMC13129786

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.